Presentation is loading. Please wait.

Presentation is loading. Please wait.

Radiotherapeutic Management of Non–Small Cell Lung Cancer in the Minimal Resource Setting  Danielle Rodin, MD, Surbhi Grover, MD, MPH, Melody J. Xu, MD,

Published byMarilynn Golden Modified over 5 years ago

Similar presentations

Presentation on theme: "Radiotherapeutic Management of Non–Small Cell Lung Cancer in the Minimal Resource Setting  Danielle Rodin, MD, Surbhi Grover, MD, MPH, Melody J. Xu, MD,"— Presentation transcript:

1 Radiotherapeutic Management of Non–Small Cell Lung Cancer in the Minimal Resource Setting 
Danielle Rodin, MD, Surbhi Grover, MD, MPH, Melody J. Xu, MD, Timothy P. Hanna, MD, MSc, Robert Olson, MD, MSc, L. John Schreiner, PhD, Anusheel Munshi, MD, DNB, MNAMS, Francoise Mornex, MD, PhD, David Palma, MD, PhD, Laurie E. Gaspar, MD, MBA  Journal of Thoracic Oncology  Volume 11, Issue 1, Pages (January 2016) DOI: /j.jtho Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

2 Figure 1 (A) An illustration of the concept of two-dimensional treatment planning. The field borders (blue line) encompass the upper mediastinum and neck and would be placed using anatomy visible on radiographs or fluoroscopy. The patient would be treated with opposing anterior and posterior beams. (B) An electronic portal image showing a patient at the time of treatment, with the field borders (blue) superimposed. Journal of Thoracic Oncology  , 21-29DOI: ( /j.jtho ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

3 Figure 2 Blocks used for beam shaping. These hand-poured metal blocks are placed into the treatment machine to attenuate the beam in selected areas. Journal of Thoracic Oncology  , 21-29DOI: ( /j.jtho ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

4 Figure 3 Radiation treatment planning and delivery for stage III non–small cell lung cancer. Normal tissues and tumor target volumes are outlined on a planning computed tomography (CT) scan (Panel A, axial; Panel B, coronal). The tumor and involved nodes are outlined (blue), and margins added for microscopic extension (green) and setup error produce the planning target volume (red color wash). The prescription dose is 60 Gy in 30 fractions, and the 95% dose line (thick yellow) and 50% dose line (thin white) are shown. Normal structures are also outlined (left lung, esophagus, heart, and spinal cord are shown). For treatment delivery, a cone beam computed tomographic image (Panel C, inset) is acquired aligned to the planning computed tomographic image (Panel C, main image) to confirm positioning. Journal of Thoracic Oncology  , 21-29DOI: ( /j.jtho ) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "Radiotherapeutic Management of Non–Small Cell Lung Cancer in the Minimal Resource Setting  Danielle Rodin, MD, Surbhi Grover, MD, MPH, Melody J. Xu, MD,"

Similar presentations

Management of independent motion between multiple targets in lung cancer radiation therapy  Feng Liu, PhD, An Tai, PhD, Ergun Ahunbay, PhD, Elizabeth.

Management of independent motion between multiple targets in lung cancer radiation therapy  Feng Liu, PhD, An Tai, PhD, Ergun Ahunbay, PhD, Elizabeth.
Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer  Shervin M. Shirvani, MD, Ann.

Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer  Shervin M. Shirvani, MD, Ann.
Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group  Joachim Yahalom,

Modern Radiation Therapy for Extranodal Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group  Joachim Yahalom,
Detection of regional radiation-induced lung injury using hyperpolarized 129Xe chemical shift imaging in a rat model involving partial lung irradiation:

Detection of regional radiation-induced lung injury using hyperpolarized 129Xe chemical shift imaging in a rat model involving partial lung irradiation:
Marked Tumor Response and Fatal Hemoptysis During Radiation for Lung Cancer in a Human Immunodeficiency Virus-Positive Patient Taking Nelfinavir  Christopher.

Marked Tumor Response and Fatal Hemoptysis During Radiation for Lung Cancer in a Human Immunodeficiency Virus-Positive Patient Taking Nelfinavir  Christopher.
Image–Guided Radiation Therapy for Non–small Cell Lung Cancer

Image–Guided Radiation Therapy for Non–small Cell Lung Cancer
Successful Osimertinib Rechallenge in a Patient with T790M-Mutant Non–Small Cell Lung Cancer after Osimertinib-Induced Interstitial Lung Disease  Eisaku.

Successful Osimertinib Rechallenge in a Patient with T790M-Mutant Non–Small Cell Lung Cancer after Osimertinib-Induced Interstitial Lung Disease  Eisaku.
Hiral P. Fontanilla, MD, Ann H. Klopp, MD, PhD, Mary E

Hiral P. Fontanilla, MD, Ann H. Klopp, MD, PhD, Mary E
Acute and Progressive Tracheal Stenosis after Proton Beam Therapy with Concurrent Chemotherapy for Non–Small Cell Lung Cancer  Yoshitaka Zenke, MD, Shigeki.

Acute and Progressive Tracheal Stenosis after Proton Beam Therapy with Concurrent Chemotherapy for Non–Small Cell Lung Cancer  Yoshitaka Zenke, MD, Shigeki.
PET/CT Fusion Scan in Lung Cancer: Current Recommendations and Innovations  Cristina Gámez, MD, PhD, Rafael Rosell, MD, PhD, Alejandro Fernández, MD, PhD,

PET/CT Fusion Scan in Lung Cancer: Current Recommendations and Innovations  Cristina Gámez, MD, PhD, Rafael Rosell, MD, PhD, Alejandro Fernández, MD, PhD,
Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer  Shervin M. Shirvani, MD, Ann.

Intensity modulated radiation therapy for definitive treatment of paraortic relapse in patients with endometrial cancer  Shervin M. Shirvani, MD, Ann.
Resectable Clinical N2 Non–Small Cell Lung Cancer; What Is the Optimal Treatment Strategy? An Update by the British Thoracic Society Lung Cancer Specialist.

Resectable Clinical N2 Non–Small Cell Lung Cancer; What Is the Optimal Treatment Strategy? An Update by the British Thoracic Society Lung Cancer Specialist.
Abscopal Effect of Nivolumab in a Patient with Primary Lung Cancer

Abscopal Effect of Nivolumab in a Patient with Primary Lung Cancer
Rash in a Patient Treated with Pemetrexed for Relapsed Non-small Cell Lung Cancer  Isabelle Declercq, MD, Yolande Lievens, MD, PhD, Eric Verbeken, MD,

Rash in a Patient Treated with Pemetrexed for Relapsed Non-small Cell Lung Cancer  Isabelle Declercq, MD, Yolande Lievens, MD, PhD, Eric Verbeken, MD,
Disparities in Treatment of Patients with Inoperable Stage I Non–Small Cell Lung Cancer: A Population-Based Analysis  Matthew Koshy, MD, Renuka Malik,

Disparities in Treatment of Patients with Inoperable Stage I Non–Small Cell Lung Cancer: A Population-Based Analysis  Matthew Koshy, MD, Renuka Malik,
Intensity-Modulated Radiotherapy After Extrapleural Pneumonectomy in the Combined- Modality Treatment of Malignant Pleural Mesothelioma  Alexander Chi,

Intensity-Modulated Radiotherapy After Extrapleural Pneumonectomy in the Combined- Modality Treatment of Malignant Pleural Mesothelioma  Alexander Chi,
Severe Local Toxicity after Lung Stereotactic Body Radiation Therapy: Lesional Abscess Leading to Bronchocutaneous Fistula Requiring Surgical Marsupialization 

Severe Local Toxicity after Lung Stereotactic Body Radiation Therapy: Lesional Abscess Leading to Bronchocutaneous Fistula Requiring Surgical Marsupialization 
A Case of Concurrent De Novo C797S and L858R EGFR Mutation Detected in Stage IA Non–Small Cell Lung Cancer Patient  Jong Sik Lee, MD, Jae Young Hur, PhD,

A Case of Concurrent De Novo C797S and L858R EGFR Mutation Detected in Stage IA Non–Small Cell Lung Cancer Patient  Jong Sik Lee, MD, Jae Young Hur, PhD,
Postoperative Proton Therapy in the Management of Stage III Thymoma

Postoperative Proton Therapy in the Management of Stage III Thymoma
Image–Guided Radiation Therapy for Non–small Cell Lung Cancer

Image–Guided Radiation Therapy for Non–small Cell Lung Cancer

Similar presentations

Ads by Google